• Tiny dataset, massive lifeline for Annovis firstwordpharma
    May 26, 2021
    Sceptics may question the robustness of an early glimpse of mid-stage data for a well-worn neurodegenerative disease candidate but it is tough to doubt how real the upside has been for Annovis Bio.
PharmaSources Customer Service